Keio University · Health Care Center

Research keywords肺非結核性抗酸菌症・Mycobacterium avium complex・新型コロナウイルスワクチン・免疫原性・感染症学

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Combined dual β-lactams and diazabicyclooctane β-lactamase inhibitor is highly effective against Mycobacterium abscessus species in vitro2025 · Journal of Global Antimicrobial Resistance 42
• Sectm1a Depletion Promotes Neutrophil Recruitment during Pneumococcal Pneumonia2025 · American Journal of Respiratory Cell and Molecular Biology 73
• Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicity2025 · Cell Genomics 5
• Oral β-lactam combinations are effective in vitro against Mycobacterium avium, regardless of clarithromycin susceptibility2025 · Microbiology Spectrum 13

• 慶應義塾の健康関連データベースを用いた、健康問題発生における危険因子の探索2025 · -
• 難治性肺非結核性抗酸菌症の新規薬物治療法開発2025 · -
• 新規肺MABC症治療薬の開発と革新的非臨床PK/PD評価法の構築2024 · -
• 肺MAC症の新規治療法開発に向けた菌細胞壁脂質の解析2023 · -

• Official profile